Literature DB >> 6079199

Beta-adrenergic blockade in the management of acute thyrotoxic crisis, tachycardia and arrhythmias.

V Parsons, D Jewitt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6079199      PMCID: PMC2466415          DOI: 10.1136/pgmj.43.506.756

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  30 in total

1.  PHARMACODYNAMIC EFFECTS OF BETA-ADRENERGIC RECEPTOR BLOCKADE IN PATIENTS WITH HYPERTHYROIDISM.

Authors:  W R WILSON; E O THEILEN; F W FLETCHER
Journal:  J Clin Invest       Date:  1964-08       Impact factor: 14.808

2.  GUANETHIDINE IN HYPERTHYROIDISM.

Authors:  S S WALDSTEIN; G H WEST; W Y LEE; D BRONSKY
Journal:  JAMA       Date:  1964-08-24       Impact factor: 56.272

3.  The thyroid and the heart.

Authors:  H COOKSON
Journal:  Br Med J       Date:  1959-01-31

4.  Thyrotoxicosis and myocardial infarction.

Authors:  G GRYTTING; H A SALVESEN
Journal:  Acta Med Scand       Date:  1957-04-18

5.  Effects of oral and intramuscular administration of reserpine in thyrotoxicosis.

Authors:  J J CANARY; M SCHAAF; B J DUFFY; L H KYLE
Journal:  N Engl J Med       Date:  1957-09-05       Impact factor: 91.245

6.  Serum free thyroxine and thyroxine-binding protein studies in patients with supraventricular tachycardias.

Authors:  D L Schatz
Journal:  J Clin Endocrinol Metab       Date:  1967-02       Impact factor: 5.958

Review 7.  Management of emergencies. IX. Thyrotoxic storm.

Authors:  S H Ingbar
Journal:  N Engl J Med       Date:  1966-06-02       Impact factor: 91.245

8.  Atrial fibrillation in thyrotoxicosis treated with radioiodine.

Authors:  J S Staffurth; M C Gibberd; P J Hilton
Journal:  Postgrad Med J       Date:  1965-11       Impact factor: 2.401

9.  The effect of epinephrine on adenosine 3', 5'-phosphate levels in the isolated perfused rat heart.

Authors:  G A Robison; R W Butcher; I Oye; H E Morgan; E W Sutherland
Journal:  Mol Pharmacol       Date:  1965-09       Impact factor: 4.436

10.  An analysis of published data on thyroxine turnover in human subjects.

Authors:  T H Oddie; J H Meade; D A Fisher
Journal:  J Clin Endocrinol Metab       Date:  1966-04       Impact factor: 5.958

View more
  16 in total

1.  Adrenergic beta-receptor blockade in hyperthyroidism.

Authors:  I Ramsay
Journal:  Br J Clin Pharmacol       Date:  1975-10       Impact factor: 4.335

Review 2.  Role of thyroid hormones in ventricular remodeling.

Authors:  Viswanathan Rajagopalan; A Martin Gerdes
Journal:  Curr Heart Fail Rep       Date:  2015-04

Review 3.  Beta-adrenergic receptor blocking drugs in hyperthyroidism.

Authors:  P Turner
Journal:  Drugs       Date:  1974       Impact factor: 9.546

4.  The use of propranolol in the surgical treatment of thyrotoxic patients.

Authors:  T C Lee; R J Coffey; J Mackin; M Cobb; J Routon; J J Canary
Journal:  Ann Surg       Date:  1973-06       Impact factor: 12.969

5.  Pindolol-induced tremor.

Authors:  H Hod; J Har-Zahav; N Kaplinsky; O Frankl
Journal:  Postgrad Med J       Date:  1980-05       Impact factor: 2.401

6.  Comparison of propranolol and LB 46 (prinodolol) on hyperthyroid tachycardia.

Authors:  A G Arbab; P Turner
Journal:  Postgrad Med J       Date:  1971-06       Impact factor: 2.401

7.  Effect of propranolol on acute withdrawal tremor in alcoholic patients.

Authors:  H Teräväinen; A Larsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-06       Impact factor: 10.154

Review 8.  Use of beta-adrenoceptor blocking drugs in hyperthyroidism.

Authors:  J Feely; N Peden
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

9.  Propranolol in the surgical management of thyrotoxicosis.

Authors:  P D Bewsher; C A Pegg; D J Stewart; D A Lister; W Michie
Journal:  Ann Surg       Date:  1974-11       Impact factor: 12.969

10.  Propranolol and thyroidectomy in the treatment of thyrotoxicosis.

Authors:  T C Lee; R J Coffey; B M Currier; X P Ma; J J Canary
Journal:  Ann Surg       Date:  1982-06       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.